ArticleInternational journal of molecular sciences2020

Linagliptin Ameliorates Hepatic Steatosis via Non-Canonical Mechanisms in Mice Treated with a Dual Inhibitor of Insulin Receptor and IGF-1 Receptor.

Tomoko Okuyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.